Form 8-K - Current report:
SEC Accession No. 0001213900-21-050034
Filing Date
2021-09-27
Accepted
2021-09-27 16:16:35
Documents
13
Period of Report
2021-09-21
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea147970-8k_silopharma.htm   iXBRL 8-K 20930
2 FORM OF STOCK PURCHASE AGREEMENT ea147970ex10-1_silopharma.htm EX-10.1 32272
  Complete submission text file 0001213900-21-050034.txt   227956

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE silo-20210921.xsd EX-101.SCH 3030
4 XBRL LABEL FILE silo-20210921_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE silo-20210921_pre.xml EX-101.PRE 22362
6 EXTRACTED XBRL INSTANCE DOCUMENT ea147970-8k_silopharma_htm.xml XML 3282
Mailing Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632
Business Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632 (718) 400-9031
Silo Pharma, Inc. (Filer) CIK: 0001514183 (see all company filings)

EIN.: 462137136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54872 | Film No.: 211281922
SIC: 2300 Apparel & Other Finishd Prods of Fabrics & Similar Matl